Even if the NIH is drastically cut, we don't see a doomsday scenario for these companies, and some of the industry's stronger players are now trading at attractive valuations.
Morningstar's Patty Oey and Dan Rohr and Columbia Acorn's Andreas Waldburg-Wolfegg offer best practices for globe-trotting investors who must navigate choppy waters in today's market.
Slowing in some emerging markets likely affects other emerging markets more than it harms the U.S. economy, says Morningstar's Bob Johnson.
2012 shows the importance of paying attention to valuations amid the doom-and-gloom headlines.
With fears of an impending Japanese sell-off and a China slowdown, as well as ongoing sovereign debt woes in Europe, many fund managers are seeking more safety when investing abroad, says Morningstar's Bridget Hughes.
BlackRock's Rick Rieder expects the bond market to focus more on alpha creation next year, but investors should watch for rising duration risk as well as ongoing troubles in Europe.
Policymakers and corporate leaders appeared to take decisive steps this week, but are they moving in the right direction?
As economic woes continue to make headlines, investors should tune out the macro noise and understand that good companies perform better in difficult times, says Sanibel Captiva's Pat Dorsey.
©2012 Morningstar Advisor. All right reserved.